Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Microbiology

Background:

• Antibiotic resistance, particularly Methicillin-resistant Staphylococcus aureus (MRSA), poses a significant global health threat.
• Novel antibacterial agents with unique mechanisms of action are urgently needed to combat resistant bacterial strains.

Purpose of the Study:

• To design, synthesize, and evaluate a series of amphiphilic norbornane derivatives as potential antibacterial agents.
• To investigate the mechanism of action of these compounds using molecular modeling and fluorescence microscopy.

Main Methods:

• Synthesis of novel norbornane-based compounds.
• Determination of Minimum Inhibitory Concentration (MIC) against MRSA.
• Molecular modeling to predict compound aggregation and membrane interaction.
• Construction of fluorescent analogues for cellular studies.
• Confocal microscopy to visualize compound localization within bacterial cells.

Main Results:

• A series of potent amphiphilic norbornane antibacterial agents were synthesized, with compound 10 exhibiting an MIC of 0.25 μg/mL against MRSA.
• Molecular modeling suggested rapid aggregation of these agents before membrane insertion.
• Fluorescent analogues (compounds 29 and 34) demonstrated good activity (MIC = 0.5 μg/mL against MRSA).
• Confocal microscopy confirmed the bacterial membrane as the primary site of interaction for these compounds.

Conclusions:

• Amphiphilic norbornane derivatives represent a promising class of antibacterial agents with potent activity against MRSA.
• The compounds appear to exert their antibacterial effect through membrane interaction, following an initial aggregation process.
• Further investigation into this class of compounds could lead to the development of new therapeutic strategies against bacterial infections.